Koshinski Asset Management
IDNA icon

Koshinski Asset Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Koshinski Asset Management’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,488
Closed -$85.7K – 1236
2022
Q1 		$85.7K Buy
2,488
+1,688
+211% +$59.6K 0.01% 890
2021
Q4 		$35K Hold
800
– – ﹤0.01% 1275
2021
Q3 		$40.6K Buy
+800
New +$41.7K ﹤0.01% 1207

Other funds holding IDNA

WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

Koshinski Asset Management's IDNA Position: Q2 2022 in Review

Koshinski Asset Management sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q2 2022, closing a stake of 2,488 shares — an estimated $85.7K sold.

Koshinski Asset Management first reported a position in IDNA in Q3 2021 and held it in 3 quarters. The position peaked at $85.7K in Q1 2022. 73 funds tracked by Wall St. Rank hold IDNA as of Q2 2022.

  • Koshinski Asset Management reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 2,488 iShares Genomics Immunology and Healthcare ETF shares in Q2 2022, an estimated $85.7K.
  • Koshinski Asset Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2021 and held it in 3 quarters.
  • Koshinski Asset Management's iShares Genomics Immunology and Healthcare ETF position peaked at $85.7K in Q1 2022.
  • 73 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.